Recent Finacing
Recent Raise
New Haven Pharmaceuticals develops controlled‑release prescription drugs and reformulations using GRAS APIs and licensed micro‑pump and zinc‑salt technologies from Yale/Flamel, targeting antiplatelet aspirin and GERD therapies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
